GSK Tightens Avandia Restrictions
By Derek Hawkins · February 7, 2011, 4:39 PM EST
Under orders from health regulators, GlaxoSmithKline PLC said Monday it had revised safety restrictions on the diabetes drug Avandia because of its links to heart attacks, in a move closely following...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login